Adam Solander Quoted in “Will Cases Spur More Focus on ‘Disability’ – and What Does This Mean for Payers?”

Specialty Pharmacy News

Adam Solander, an Associate of the Firm in the Health Care & Life Sciences practice in the Washington, DC office, was quoted in an article titled "Will Cases Spur More Focus on ‘Disability' – and What Does This Mean for Payers?"

Following is an excerpt:

Adam Solander, an associate at Epstein Becker Green, tells SPN that this is a "whole different set of complaints than we've seen before." The lawsuits, he says, are a "byproduct of the environment and the shifting law… In different areas, I think we'll see more complaints," and it will be interesting to see "how they figure out how the law applies to them. There are a lot of moving pieces that need to solidify."